NEW CANAAN, Conn., July 28, 2026
FlyteHealth has achieved General Availability within the Centers for Medicare & Medicaid Services (CMS) Health Technology Ecosystem, marking a significant milestone in the expansion of digital healthcare for Medicare beneficiaries. The recognition was announced during the Health Technology Ecosystem’s one-year anniversary event in Washington, D.C., hosted by the U.S. Department of Health and Human Services (HHS) and CMS. The achievement confirms that FlyteHealth has successfully met CMS’s stringent patient-facing technology requirements, making its AI-enabled cardio-kidney-metabolic (eCKM) care platform available to eligible Medicare beneficiaries. The platform is designed to provide comprehensive, connected care for individuals living with hypertension, hyperlipidemia, obesity, prediabetes, diabetes, chronic kidney disease, and cardiovascular disease, helping improve clinical outcomes through personalized, data-driven healthcare. The milestone strengthens FlyteHealth’s position as an innovator in digital chronic disease management while supporting CMS’s broader initiative to modernize patient-centered healthcare technology.
CMS Recognition Validates Connected Digital Healthcare Platform
Achieving General Availability within the CMS Health Technology Ecosystem demonstrates that FlyteHealth has successfully delivered on its commitment to providing secure, patient-centered digital healthcare. To meet CMS requirements, the company implemented IAL2-level identity verification, earned Digital Medicine Society (DiMe) certification under the CARIN Code of Conduct, and enabled secure retrieval of patient health records from CMS-Aligned Networks without requiring multiple patient portal logins. The platform places patients in full control of their healthcare information while securely integrating laboratory results, medication histories, diagnoses, and other clinical data into a unified care experience. This connected infrastructure enables healthcare providers to make more informed clinical decisions while simplifying access to personalized care for Medicare beneficiaries managing multiple chronic conditions.
AI-Driven Cardio-Kidney-Metabolic Care Improves Patient Outcomes
At the core of the FlyteHealth platform is an AI-enabled clinical intelligence system that analyzes integrated health information to guide patients into personalized prevention, treatment, and long-term disease management pathways. The company’s early cardio-kidney-metabolic (eCKM) care model focuses on addressing interconnected chronic diseases through multidisciplinary clinical care, medication optimization, behavioral health support, and continuous care coordination. Independent evaluations have demonstrated encouraging clinical outcomes, including 86% patient adherence at 12 months, an average 16.6% weight reduction, and measurable improvements in blood pressure, hemoglobin A1c, and LDL cholesterol. Additional healthcare economic analyses also reported substantial reductions in overall medical and pharmacy expenditures, highlighting the platform’s potential to improve patient outcomes while lowering healthcare costs through proactive chronic disease management.
Advertisement
Digital Innovation Supports the Future of Medicare Care
FlyteHealth’s achievement reflects the growing role of digital health technologies, artificial intelligence, and secure health data integration in transforming chronic disease management across the U.S. healthcare system. By combining advanced analytics with personalized clinical decision support, the platform enables scalable, precision-driven care that addresses the complex relationship between cardiovascular, kidney, metabolic, and obesity-related diseases. The company’s recognition within the CMS Health Technology Ecosystem further validates its commitment to delivering secure, interoperable healthcare solutions that align with federal digital health initiatives. As healthcare increasingly shifts toward connected, patient-centered models, FlyteHealth is positioned to play an important role in expanding access to high-quality digital care while supporting better long-term outcomes for Medicare beneficiaries living with chronic cardiometabolic conditions.
Source: FlyteHealth press release
